Showing results (71-80 of 78) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Nature Medicine|August 31, 2023
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim resultsSpyros Chalkias, Jordan L Whatley, Frank Eder, et al.Nature Biotechnology|February 2, 2016
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivoHao Yin, Chun-Qing Song, Joseph R Dorkin, et al.Nature Biotechnology|November 14, 2017
Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editingHao Yin, Chun-Qing Song, Sneha Suresh, et al.Genome Medicine|August 23, 2023
Long-read sequencing identifies a common transposition haplotype predisposing for CLCNKB deletionsNikolai Tschernoster, Florian Erger, Stefan Kohl, et al.The Lancet. Primary Care|June 18, 2026
Chemical adherence testing-guided intervention versus standard of care in patients with hypertension who are non-adherent to antihypertensive treatment in the UK (OUTREACH): a multicentre, randomised controlled trialMaciej Tomaszewski, Pankaj Gupta, Philip Chowienczyk, et al.Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300)Stephen Walsh, William O Hahn, Wilton B Williams, et al.Nature Medicine|May 13, 2022
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trialBoris Julg, Kathryn E Stephenson, Kshitij Wagh, et al.Research Square|May 19, 2023
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) TrialAngela Branche, Nadine Rouphael, David Diemert, et al.Pageof 8